AstraZeneca Pharmaceuticals LP
FDA inspection history in Philadelphia, Pennsylvania, 2022
- 1
- Form 483
Every document, by year
- Form 483
2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2022One Form 483, at Philadelphia, Pennsylvania.
Cited most
Across all AstraZeneca Pharmaceuticals observations on file
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.192Production record review1
- 21 CFR 211.63Equipment design, size, and location1
The complete AstraZeneca Pharmaceuticals file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Philadelphia, Pennsylvania
One Form 483 · 2022 · 3 observations
Latest: Form 483, Jul 22, 2022 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-07-22 | 483 Form 483 | Philadelphia, Pennsylvania | 3 | $99 |
Investigators on these documents
FEI number 3004829714 · most recent document Jul 22, 2022
About AstraZeneca Pharmaceuticals LP
How many FDA Form 483s has AstraZeneca Pharmaceuticals LP received?
FDA Intel has 1 Form 483 on file for AstraZeneca Pharmaceuticals LP; the most recent is dated Jul 22, 2022.
When was AstraZeneca Pharmaceuticals LP last inspected by FDA?
The most recent FDA inspection document on file for AstraZeneca Pharmaceuticals LP is a Form 483 dated Jul 22, 2022, for the site in Philadelphia, Pennsylvania.
What did FDA cite at AstraZeneca Pharmaceuticals LP?
The regulations cited most in the observations on file for AstraZeneca Pharmaceuticals LP are 21 CFR 211.113(b) (Control of microbiological contamination), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.63 (Equipment design, size, and location), 1 time.